Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;24(1):41-50.
doi: 10.1111/tbj.12830. Epub 2017 Jun 8.

The role of skin ulceration in breast carcinoma staging and outcome

Affiliations

The role of skin ulceration in breast carcinoma staging and outcome

Thaer Khoury et al. Breast J. 2018 Jan.

Abstract

Breast carcinoma with skin ulceration (SU) is considered a locally advanced disease. The purpose of the study is to investigate if SU is an independent adverse factor. Breast carcinoma patients with SU (n=111) were included in the study. A subset (n=38, study cohort) was matched with cases that had no SU (n=38, matched cohort); the survival analyses were compared between these groups. Then, cases (n=80) were staged independent from SU into stage I, II or III. Disease free survival (DFS) and overall survival (OS) were analyzed. Patients with larger tumors tended to present with distant metastases more often than patients with smaller tumors (P=.004). In the matched cases, the 5-year DFS probability was 53% for the study cohort and 58% for the matched cohort; and for OS 75% for the study cohort and 84% for the matched cohort with no statistical significant difference. However, there was a trend towards worse DFS for the patients whose tumors had SU. When the cases were staged based on tumor size and node status (I, II or III), the OS was statistically significant (P=.047) but not the DFS (P=.195). Relatively small tumors with SU had an extent of disease similar to that observed in patients with early stages disease. The survival analysis suggests that SU may not be an adverse factor. However, more cases are needed to further examine this finding.

Keywords: breast carcinoma; skin ulceration; staging; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival curves for study and matched cohorts; A, OS and B, DFS.
Figure 2
Figure 2
Survival curves based on tumor size (T1, T2, T3) including stage-IV cases (A and B) and excluding stage-IV (C and D); A, OS including stage-IV; B, DFS including stage-IV; C, OS excluding stage-IV; and D, DFS excluding stage-IV.
Figure 3
Figure 3
Survival curves based on tumor stage (stage I, II and III); A, OS and B, DFS.
Figure 4
Figure 4
Barplot of 5 year survival by size of tumor and number of positive lymph nodes.
Figure 5
Figure 5
Survival curves based on tumor stage considering all cases as pT4b; A, OS and B, DFS.
Figure 6
Figure 6
Survival curves; A, OS based on age; B, OS based on Anti-HER2 therapy; C, DFS based on tumor focality (multifocal vs. unifocal); D, DFS based on margin status (positive vs. negative); E, DFS based on lymph node status (negative vs. at least one positive); F, OS based on best tumor size cutoff (1.7-cm)

References

    1. Sugg S, Donegan W. Staging and prognosis. In: Donegan W, Spratt J, editors. Cancer of the breast. 5. Philadelphia: Saunders; 2002. pp. 477–506.
    1. Page D, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7. New York: Springer; 2010. Part IIV Breast; pp. 345–369.
    1. Güth U, Wight E, Schotzau A, et al. Breast carcinoma with noninflammatory skin involvement (T4b): time to abandon an historic relic from the TNM classification. Cancer. 2005;104(9):1862–1870. - PubMed
    1. Güth U, Huang D, Holzgreve W, Wight E, Singer G. T4 breast cancer under closer inspection: a case for revision of the TNM classification. Breast. 2007;16:625–636. - PubMed
    1. Güth U, Singer G, Schötzau A, et al. Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey. Ann Oncol. 2005;16(10):1618–1623. - PubMed

Publication types